These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 36696935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice.
    Mitra S, Barman S, Nag D, Sinha R, Saha DR, Koley H.
    FEMS Immunol Med Microbiol; 2012 Nov; 66(2):240-50. PubMed ID: 22762732
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice.
    Camacho AI, Irache JM, de Souza J, Sánchez-Gómez S, Gamazo C.
    Vaccine; 2013 Jul 11; 31(32):3288-94. PubMed ID: 23727423
    [Abstract] [Full Text] [Related]

  • 6. Shigella-Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei.
    Clarkson KA, Porter CK, Talaat KR, Frenck RW, Alaimo C, Martin P, Bourgeois AL, Kaminski RW.
    mSphere; 2021 Aug 25; 6(4):e0012221. PubMed ID: 34259559
    [Abstract] [Full Text] [Related]

  • 7. Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice.
    Camacho AI, de Souza J, Sánchez-Gómez S, Pardo-Ros M, Irache JM, Gamazo C.
    Vaccine; 2011 Oct 26; 29(46):8222-9. PubMed ID: 21911022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Passive immunity with multi-serotype heat-killed Shigellae in neonatal mice.
    Barman S, Koley H, Nag D, Shinoda S, Nair GB, Takeda Y.
    Microbiol Immunol; 2014 Aug 26; 58(8):463-6. PubMed ID: 24909404
    [Abstract] [Full Text] [Related]

  • 10. Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.
    Dharmasena MN, Osorio M, Takeda K, Stibitz S, Kopecko DJ.
    Clin Vaccine Immunol; 2017 Dec 26; 24(12):. PubMed ID: 29046309
    [Abstract] [Full Text] [Related]

  • 11. A broadly immunogenic polyvalent Shigella multiepitope fusion antigen protein protects against Shigella sonnei and Shigella flexneri lethal pulmonary challenges in mice.
    Li S, Anvari S, Ptacek G, Upadhyay I, Kaminski RW, Sack DA, Zhang W.
    Infect Immun; 2023 Nov 16; 91(11):e0031623. PubMed ID: 37795982
    [Abstract] [Full Text] [Related]

  • 12. Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.
    Kelly M, Janardhanan J, Wagh C, Verma S, Charles RC, Leung DT, Kamruzzaman M, Pansuriya RK, Chowdhury F, Vann WF, Kaminski RW, Khan AI, Bhuiyan TR, Qadri F, Kováč P, Xu P, Ryan ET.
    Vaccine; 2024 Oct 24; 42(24):126263. PubMed ID: 39217775
    [Abstract] [Full Text] [Related]

  • 13. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.
    Citiulo F, Necchi F, Mancini F, Rossi O, Aruta MG, Gasperini G, Alfini R, Rondini S, Micoli F, Rappuoli R, Saul A, Martin LB.
    PLoS Negl Trop Dis; 2021 Oct 24; 15(10):e0009826. PubMed ID: 34644291
    [Abstract] [Full Text] [Related]

  • 14. Protective immunity by oral immunization with heat-killed Shigella strains in a guinea pig colitis model.
    Barman S, Koley H, Ramamurthy T, Chakrabarti MK, Shinoda S, Nair GB, Takeda Y.
    Microbiol Immunol; 2013 Nov 24; 57(11):762-71. PubMed ID: 24033533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection.
    Talaat KR, Alaimo C, Martin P, Bourgeois AL, Dreyer AM, Kaminski RW, Porter CK, Chakraborty S, Clarkson KA, Brubaker J, Elwood D, Frölich R, DeNearing B, Weerts H, Feijoo BL, Halpern J, Sack D, Riddle MS, Fonck VG.
    EBioMedicine; 2021 Apr 24; 66():103310. PubMed ID: 33862589
    [Abstract] [Full Text] [Related]

  • 17. Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study.
    Chisenga CC, Bosomprah S, Simuyandi M, Mwila-Kazimbaya K, Chilyabanyama ON, Laban NM, Bialik A, Asato V, Meron-Sudai S, Frankel G, Cohen D, Chilengi R.
    PLoS One; 2021 Apr 24; 16(5):e0252222. PubMed ID: 34043697
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry.
    Kelly M, Mandlik A, Charles RC, Verma S, Calderwood SB, Leung DT, Biswas R, Islam K, Kamruzzaman M, Chowdhury F, Khanam F, Vann WF, Khan AI, Bhuiyan TR, Qadri F, Vortherms AR, Kaminski R, Kováč P, Xu P, Ryan ET.
    Vaccine; 2023 Jul 31; 41(34):4967-4977. PubMed ID: 37400283
    [Abstract] [Full Text] [Related]

  • 20. Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies.
    Camacho AI, Souza-Rebouças J, Irache JM, Gamazo C.
    Methods; 2013 May 01; 60(3):264-8. PubMed ID: 23046911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.